Intelligent nebulizers in the age of the Internet: The I-neb Adaptive Aerosol Delivery (AAD) System

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 23, Issue SUPPL. 1, 2010, Pages

  Dhand, Rajiv ^a,b,c  

^a Department of Medicine ^*  (United States)

^b UNIVERSITY OF MISSOURI   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTIBIOTIC AGENT; BRONCHODILATING AGENT; CORTICOSTEROID; ILOPROST; IPRATROPIUM BROMIDE; MUCOLYTIC AGENT; SODIUM CHLORIDE;

ACCURACY; ACUTE DISEASE; AEROSOL; ALGORITHM; ANTIBIOTIC THERAPY; ARTIFICIAL VENTILATION; BREATHING; BREATHING PATTERN; CHRONIC DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER PROGRAM; CORTICOSTEROID THERAPY; COST; CYSTIC FIBROSIS; DRUG DELIVERY SYSTEM; EDITORIAL; EUROPE; FORCED EXPIRATORY VOLUME; HUMAN; HYPERVENTILATION; INTERNET; LUNG CAPACITY; METERED DOSE INHALER; NEBULIZATION; NEBULIZER; PHARMACY; POWDER INHALER; PULMONARY HYPERTENSION; RESIDUAL VOLUME; TACHYPNEA; TELEHEALTH; UNITED STATES;

ADMINISTRATION, INHALATION; AEROSOLS; DRUG DELIVERY SYSTEMS; HUMANS; INTERNET; MEDICATION ADHERENCE; NEBULIZERS AND VAPORIZERS; PHARMACEUTICAL PREPARATIONS; TECHNOLOGY, PHARMACEUTICAL; TELEMEDICINE;

EID: 77950617287     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2010.0818     Document Type: Editorial

References (17)

1. Denyer J, and Dyche T: The Adaptive Aerosol Delivery (AAD) technology: past, present and future. J Aerosol Med Pulm Drug Del. 2010;23(Suppl 1):S-1-S-10.
2. Hardaker LEA, and Hatley RHM: In vitro characterization of the I-neb Adaptive Aerosol Delivery (AAD) System. J Aerosol Med Pulm Drug Del. 2010;23(Suppl 1):S-11-S-20.
3. Nikander K, Denyer J, Dodd M, Dyche T, Webb K, Weller P, and Stableforth D: The Adaptive Aerosol Delivery System in a telehealth setting: patient acceptance, performance, and feasibility. J Aerosol Med Pulm Drug Del. 2010;23(Suppl 1): S-21-S-27.
4. Nikander K, Prince I, Coughlin S, Warren S, and Taylor G: Mode of breathing-Tidal or slow and deep-through the I-neb Adaptive Aerosol Delivery (AAD) system affects lung deposition of 99mTc-DTPA. J Aerosol Med Pulm Drug Del. 2010;23(Suppl 1):S-37-S-43.
5. Denyer J, Prince I, Dixon E, Agent P, Pryor J, and Hodson M: Evaluation of the Target Inhalation Mode (TIM) breathing maneuver in simulated nebulizer therapy in patients with cystic fibrosis. J Aerosol Med Pulm Drug Del. 2010;23(Suppl 1): S-29-S-36.
6. Denyer J, Black A, Nikander K, Dyche T, and Prince I: Domiciliary experience of the Target Inhalation Mode (TIM) breathing maneuver in patients with cystic fibrosis. J Aerosol Med Pulm Drug Del. 2010;23(Suppl 1):S-45-S-54.
7. Geller DE, and Kesser KC: The I-neb Adaptive Aerosol Delivery System enhances aerosol delivery of a1-antitrypsin with controlled inhalation. J Aerosol Med Pulm Drug Del. 2010;23(Suppl 1):S-55-S-59.
8. Goodman N, Morgan M, Nikander K, Hinch S, and Coughlin S: Evaluation of patient-reported outcomes and quality of life with the I-neb AAD system in patients with chronic obstructive pulmonary disease. J Aerosol Med Pulm Drug Del. 2010;23(Suppl 1):S-61-S-70.
9. Rau JL: Design principles of liquid nebulization devices currently in use. Respir Care. 2002;47:1257-1275.
10. Dhand R: Nebulizers that use a vibrating mesh or plate with multiple apertures to generate aerosol. Respir Care. 2002;47: 1406-1416.
11. Van Dyke R, and Nikander K: Delivery of iloprost inhalation solution with HaloLite, Prodose, and I-neb Adaptive Aerosol Delivery (AAD) systems-an in vitro study. Respir Care. 2007;53:184-190.
12. Dhand R, Giri VV, Noth I, Lissin D, Fishman RS, and Taylor K: Bronchodilator response to ipratropium delivered via Aerodose inhaler or Pari LC Plus nebulizer in COPD. Am J Respir Crit Care Med. 2002;165:A593.
13. Newman SP, Pavia D, Garland N, and Clarke SW: Effects of various inhalation modes on the deposition of radioactive pressurized aerosols. Eur J Respir Dis. 1982;63(Suppl):57-65.
14. Bennett WD, and Smaldone GC: Human variation in the peripheral air-space deposition of inhaled particles. J Appl Physiol. 1987;62:1603-1610.
15. Brand P, Schulte M, Wencker M, Herpich CH, Klein G, Hanna K, and Meyer T: Lung deposition of inhaled alpha 1- proteinase inhibitor in cystic fibrosis and alpha1-antitrypsin deficiency. Eur Respir J. 2009;34:354-360.
16. Sander N, Fusco-Walkert SJ, Harder JM, and Chipps BE: Dose counting and the use of pressurized metered-dose inhalers: running on empty. J Allergy Asthma Immunol. 2006; 97:34-38.
17. McNamara P, McCormack P, McDonald AJ, Heaf L, and Southern KW: Open adherence monitoring using data download from an adaptive aerosol delivery nebulizer in children with cystic fibrosis. J Cystic Fibrosis. 2009;8:258-263.